Takeda Pharmaceutical Company Limited (TAK) 13D/13G Filings for Shattuck Labs, Inc. (STTK)

Takeda Pharmaceutical Company Limited 13D and 13G filings for Shattuck Labs, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-01-14
06:06 am
Sale
2021-12-3113GSHATTUCK LABS INC
STTK
TAKEDA PHARMACEUTICAL CO LTD
TAK
2,090,858
4.950%
-9,454decrease
(-0.45%)
Filing